Jenburkt Pharmaceuticals Limited (BOM:524731)
India · Delayed Price · Currency is INR 1,034.40
-5.65 (-0.54%)
At close: Sep 4, 2026
Jenburkt Pharmaceuticals Market Cap
Jenburkt Pharmaceuticals has a market cap or net worth of 4.57 billion as of September 4, 2026. Its market cap has decreased by -12.95% in one year.
Market Cap
4.57B
Enterprise Value
4.12B
Revenue
1.69B
Ranking
n/a
PE Ratio
13.91
Stock Price
1,034.40
ChartMarket Cap Chart
Since November 21, 2001, Jenburkt Pharmaceuticals's market cap has increased from 33.01M to 4.57B, an increase of 13,729.49%. That is a compound annual growth rate of 21.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 4.57B | -5.08% |
| Dec 31, 2025 | 4.81B | -10.28% |
| Dec 31, 2024 | 5.36B | 78.59% |
| Dec 29, 2023 | 3.00B | 1.25% |
| Dec 30, 2022 | 2.96B | 21.19% |
| Dec 31, 2021 | 2.45B | 24.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ZIM Laboratories | 6.72B |
| Kilitch Drugs (India) | 6.30B |
| Albert David | 4.90B |
| Trident Lifeline | 3.50B |
| Medicamen Biotech | 3.44B |
| Ambalal Sarabhai Enterprises | 3.35B |
| Medico Remedies | 3.30B |
| BDH Industries | 2.98B |